The estimated Net Worth of Sean Kirk is at least $1.06 Milión dollars as of 6 April 2020. Mr. Kirk owns over 16,094 units of Emergent Biosolutions Inc stock worth over $95,162 and over the last 5 years he sold EBS stock worth over $965,640. In addition, he makes $0 as Executive Vice President a Manufacturing and Technical Operations at Emergent Biosolutions Inc.
Sean has made over 1 trades of the Emergent Biosolutions Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 16,094 units of EBS stock worth $965,640 on 6 April 2020.
The largest trade he's ever made was selling 16,094 units of Emergent Biosolutions Inc stock on 6 April 2020 worth over $965,640. On average, Sean trades about 4,024 units every 0 days since 2020. As of 6 April 2020 he still owns at least 12,571 units of Emergent Biosolutions Inc stock.
You can see the complete history of Mr. Kirk stock trades at the bottom of the page.
Sean Kirk serves as Executive Vice President, Manufacturing and Technical Operations of the Company. Mr. Kirk joined us in 2003 and has served as executive vice president, manufacturing and technical operations since April 2019. Prior to this position, Mr. Kirk has held various senior leadership roles including senior vice president, manufacturing operations and contract development and manufacturing operations (CDMO) business unit lead from April 2017 to March 2019, senior vice president, biodefense operations from November 2015 to March 2017, senior vice president, biosciences operations from February 2014 to November 2015 and senior vice president, biodefense vaccines and therapeutics development from March 2012 to February 2014. Mr. Kirk also served in multiple roles of increasing responsibility at our manufacturing operations site in Lansing, Michigan. Before joining us, Mr. Kirk worked at Merial, a multinational animal health company, serving in various positions from 1996 to 2001. Mr. Kirk received both an M.B.A. and B.S. in Microbiology from the University of Georgia.
Sean Kirk is 45, he's been the Executive Vice President a Manufacturing and Technical Operations of Emergent Biosolutions Inc since 2019. There are 21 older and no younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
Sean's mailing address filed with the SEC is 400 PROFESSIONAL DRIVE, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over $131,382,266 worth of Emergent Biosolutions Inc stock and bought 4,647 units worth $138,981 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri a Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of $147,206. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth $61,100.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: